Cargando…

Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists

Pulmonary Arterial Hypertension is regarded as a devastating disease, complicating Connective Tissue Diseases. Although much progress has been achieved in the last 20 years, several unfulfilled needs in diagnosis and management of PAH in these patients may still be identified. After a systematic rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Demerouti, Eftychia, Tsangaris, Iraklis, Dimitroulas, Theodoros, Giannakoulas, George, Katsimpri, Pelagia, Mitrouska, Ioanna, Orfanos, Stylianos, Skoularigkis, Ioannis, Voulgari, Paraskevi, Sfikakis, Petros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045968/
https://www.ncbi.nlm.nih.gov/pubmed/32185347
http://dx.doi.org/10.31138/mjr.30.2.90
Descripción
Sumario:Pulmonary Arterial Hypertension is regarded as a devastating disease, complicating Connective Tissue Diseases. Although much progress has been achieved in the last 20 years, several unfulfilled needs in diagnosis and management of PAH in these patients may still be identified. After a systematic review of the literature and integrating results from the latest research articles, key clinical issues for the screening and diagnosis of Pulmonary Arterial Hypertension in Connective Tissue Disorder Patients and specifically Scleroderma patients are described in this article, allowing physicians to contribute to early diagnosis of patients with Scleroderma-associated Pulmonary Arterial Hypertension.